参考文献

[1] Yu S，Liu R，Zhao G，et al. The prevalence and burden of primary headaches in China：a population-based door-to-door survey.Headache，2012，52(4)：582-591.

[2] L.Bendtsena L，Eversb S，Linde M，et al. EFNS guideline on the treatment of tension-type headache—report of an EFNS task force.Eur JNeurol，2010，17(11)：1318-1325.

[3] Kaniecki RG.Tension-type headache.Continuum(Minneap Minn)，2012，18(4)：823-834.

[4] Schievink WI.Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension.JAMA，2006，295(19)：2286-2296.

[5] 中华医学会疼痛分会头面痛学组.中国偏头痛指南.中国疼痛医学杂志，2011，17：65-86.

[6] Holland S，Silberstein SD，Freitag F，et al. Evidencebased guideline update：NSAIDs and other complementary treatments for episodic migraine prevention in adults：report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.Neurology，2012，78(17)：1346-1353.

[7] Headache Classification Subcommitte of the International Headache Society.The Internatuinal Classification of Headache Disorders，3rd edition(beta version).Cephalagia，2013，33(9)：629-808.

[8] Giacomozzi AR，Vindas AP，Silva AA，et al. Latin American consensus on guidelines for chronicmigraine treatment.Arq Neuropsiquiatr，2013，71(7)：478-486.

[9] Janis JE，Barker JC，Javadi C，et al. A review of current evidence in the surgical treatment of migraine headaches.PlastReconstr Surg，2014，134(4 Suppl 2)：131s-141s.

[10] Bigal ME，Walter S.Monclonal antibodies for migraine：preventing calcitonin gene-related peptide activity.CNS Drugs，2014，28(5)：389-399.

[11] Cruccu G，Gronseth G，Alksne J，et al. AAN-EFNS guidelines on trigeminal neuralgia management.Eur J Neurol，2008，15(10)：1013-1028.

[12] SaperJR，Da Silva AN.Medication overuse headache：history，Ffatures，prevention and management strategies.CNSDrugs，2013，27(11)：867-877.

[13] Katsaravaa Z，Obermann M.Medication-overuse headache.Curr Opin Neurol，2013，26：276-281.

[14] Evers S，Jensen R.Treatment of medication overuse headache-guideline of the EFNS headache panel.Eur J Neurol，2011，18(9)：1115-1121.